Evidence map›Paper›PMID 26969294›Full record

ArticleBMC microbiology2016

High genetic diversity of Staphylococcus aureus strains colonising the nasopharynx of Gambian villagers before widespread use of pneumococcal conjugate vaccines.

Chinelo Ebruke, Michel M Dione, Brigitte Walter, Archibald Worwui, Richard A Adegbola, Anna Roca, Martin Antonio

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Ecology and Genetic Lineages of NasalPathogens (Basel, Switzerland) · 2021
    Review
  9. Pathogens (Basel, Switzerland) · 2020
    Article
  10. Article
  11. mBio · 2018
    Article
  12. Hospital Epidemiology of Methicillin-ResistantBioMed research international · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Chinelo EbrukeVaccine and Immunity Theme, Medical Research Council Unit, Banjul, The Gambia.
Michel M DioneVaccine and Immunity Theme, Medical Research Council Unit, Banjul, The Gambia.
Brigitte WalterVaccine and Immunity Theme, Medical Research Council Unit, Banjul, The Gambia.
Archibald WorwuiVaccine and Immunity Theme, Medical Research Council Unit, Banjul, The Gambia.
Richard A AdegbolaGlaxoSmithKline Vaccines, Wavre, Belgium.
Anna RocaDisease Control and Elimination, Medical Research Council Unit, Banjul, The Gambia.
Martin AntonioVaccine and Immunity Theme, Medical Research Council Unit, Banjul, The Gambia. mantonio@mrc.gm.
MRC Unit the Gambia · GMGlaxoSmithKline (Belgium) · BELondon School of Hygiene & Tropical Medicine · GB

Funding

Medical Research Council MC_U190074190Medical Research Council MC_U190081991Medical Research Council MC_U190085849
6 · The paper itself

Abstract

backgroundWith the global efforts of reducing pneumococcal disease through widespread introduction of pneumococcal vaccines, concerns have emerged on the potential increase of morbidity and mortality from S. aureus disease. Little is known however, of the carriage rates of S. aureus or of its' relationship with carriage of S. pneumoniae in rural Africa, and West Africa in particular where very high rates of carriage of S. pneumoniae have been reported. This study aims to evaluate the prevalence, antibiotic susceptibility patterns and genotypes of S. aureus isolated from the nasopharynx of healthy individuals in rural Gambia before the introduction of routine use of pneumococcal conjugate vaccines in the country.

resultsOverall prevalence of S. aureus nasopharyngeal carriage was 25.2%. All S. aureus isolates tested were susceptible to methicillin. Resistant was observed for sulphamethoxazole-trimethoprim (15%) and tetracycline (34.3%). We found 59 different sequence types (ST), 35 of which were novel. The most prevalent sequence types were ST 15 (28%) and ST 5 (4%). Eighty two percent (494/600) of study individuals were S. pneumoniae carriers with S. pneumoniae carriage rates decreasing with increasing age groups. S. aureus carriage among pneumococcal carriers was slightly lower than among non-pneumococcal carriers (24.3 versus 29.3%; p = 0.324). There were no associations of carriage between these two bacteria across the 4 age groups. However, analysis of pooled data children < 2 years and children 2 to < 5 years of age showed a statistically significant inverse association (24.1 and 50.0% for S. aureus carriage among S. pneumoniae carriers and non-carriers respectively; p = 0.015).

conclusionsWe report that nasopharyngeal carriage of S. aureus in rural Gambia is high in all age groups, with approximately 1 out of 4 individuals being carriers in the pre-pneumococcal vaccination era. There are indications that nasopharyngeal carriage of S.aureus could be inversely related to carriage of S. pneumoniae amongst younger children in The Gambian and that S. aureus clones in The Gambia show significant genetic diversity suggesting worldwide dissemination. Findings from this study provide a useful background for impact studies evaluating the introduction of pneumococcal vaccines or other interventions targeting the control of S. aureus infections and disease.

Indexed as

AdolescentCarrier StateChildChild, PreschoolFemaleGambiaGenetic VariationHumansInfantMaleNasopharynxPneumococcal InfectionsPneumococcal VaccinesRural HealthStaphylococcus aureusStreptococcus pneumoniaePneumococcal VaccinesVaccines, ConjugateAntibiotic resistanceColonizationGenotypesStaphylococcus aureusStreptococcus pneumoniaeThe Gambia

Identifiers

PMID26969294
PMCPMC4788959
OpenAlexW2295398810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.